BenQ Medical Technology (4116) — Cash Flow Reinvestment Rate
BenQ Medical Technology (4116) has a Cash Flow Reinvestment Rate of 0.42x as of June 2025, reinvesting NT$76.10 Million (capex NT$14.79 Million plus investments NT$-61.31 Million) from operating cash flow of NT$179.07 Million. See 4116 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
BenQ Medical Technology Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for BenQ Medical Technology across 8 annual periods. For the full cash flow conversion analysis, see how efficiently does BenQ Medical Technology generate cash.
Annual Cash Flow Reinvestment Rate for BenQ Medical Technology (2017–2024)
Year-by-year capital reinvestment analysis for BenQ Medical Technology. See BenQ Medical Technology (4116) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.88x | NT$195.80 Million | NT$222.22 Million | NT$175.48 Million | ▲ +45.5% |
| 2023 | 0.61x | NT$267.96 Million | NT$442.35 Million | NT$139.28 Million | ▲ +39.9% |
| 2022 | 0.43x | NT$164.04 Million | NT$378.77 Million | NT$60.05 Million | ▼ -45.2% |
| 2021 | 0.79x | NT$95.91 Million | NT$121.35 Million | NT$32.92 Million | ▲ +54.4% |
| 2020 | 0.51x | NT$77.53 Million | NT$151.48 Million | NT$42.37 Million | ▲ +205.9% |
| 2019 | 0.17x | NT$28.32 Million | NT$169.23 Million | NT$21.15 Million | ▼ -57.1% |
| 2018 | 0.39x | NT$49.21 Million | NT$126.10 Million | NT$31.36 Million | ▼ -77.9% |
| 2017 | 1.77x | NT$128.91 Million | NT$72.97 Million | NT$112.31 Million | — |